Immunic, Inc. (IMUX)
15.80
+0.40
(+2.60%)
USD |
NASDAQ |
Aug 31, 16:00
15.84
+0.04
(+0.25%)
After-Hours: 20:00
Immunic Total Long Term Debt (Quarterly) : 0.328M for June 30, 2026
Total Long Term Debt (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.328M |
| March 31, 2026 | 0.146M |
| December 31, 2025 | 0.107M |
| September 30, 2025 | 0.126M |
| June 30, 2025 | 0.205M |
| March 31, 2025 | 0.21M |
| December 31, 2024 | 0.264M |
| September 30, 2024 | 0.186M |
| June 30, 2024 | 0.241M |
| March 31, 2024 | 0.433M |
| December 31, 2023 | 0.639M |
| September 30, 2023 | 0.789M |
| June 30, 2023 | 1.214M |
| March 31, 2023 | 1.352M |
| December 31, 2022 | 0.992M |
| September 30, 2022 | 0.759M |
| June 30, 2022 | 0.407M |
| March 31, 2022 | 0.502M |
| December 31, 2021 | 0.584M |
| September 30, 2021 | 0.701M |
| June 30, 2021 | 0.829M |
| March 31, 2021 | 0.922M |
| December 31, 2020 | 0.679M |
| September 30, 2020 | 0.735M |
| June 30, 2020 | 0.793M |
| Date | Value |
|---|---|
| March 31, 2020 | 0.471M |
| December 31, 2019 | 0.52M |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.00 |
| December 31, 2018 | 37.19M |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 59.55M |
| Sionna Therapeutics, Inc. | 6.692M |
| Alnylam Pharmaceuticals, Inc. | 2.942B |
| Anika Therapeutics, Inc. | 23.32M |
| Savara, Inc. | 30.11M |